Prelude Capital Management, LLC Baxter International Inc Transaction History

Prelude Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$37.88 - $43.77 $275,652 - $318,514	7,277 New	7,277 $311,000
Q2 2023 Aug 14, 2023	BUY	$39.98 - $47.68 $101,429 - $120,964	2,537 Added 46.47%	7,997 $364,000
Q1 2023 May 15, 2023	BUY	$37.58 - $52.57 $205,186 - $287,032	5,460 New	5,460 $221,000
Q4 2020 Feb 16, 2021	SELL	$75.39 - $82.36 $1.04 Million - $1.13 Million	-13,737 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$78.33 - $90.73 $1.08 Million - $1.25 Million	13,737 New	13,737 $1.11 Million
Q2 2020 Aug 14, 2020	SELL	$78.66 - $94.14 $47,982 - $57,425	-610 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$71.57 - $93.3 $531,335 - $692,659	-7,424 Reduced 92.41%	610 $50,000
Q4 2019 Feb 14, 2020	SELL	$76.7 - $88.45 $165,135 - $190,432	-2,153 Reduced 21.13%	8,034 $672,000
Q3 2019 Nov 14, 2019	SELL	$81.4 - $89.78 $3,093 - $3,411	-38 Reduced 0.37%	10,187 $891,000
Q2 2019 Aug 14, 2019	BUY	$73.44 - $82.41 $745,048 - $836,049	10,145 Added 12681.25%	10,225 $837,000
Q1 2019 May 15, 2019	BUY	$64.48 - $81.31 $5,158 - $6,504	80 New	80 $7,000

996

449M

1.97M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $18.2B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.